Companies Developing Health Products and Ebola Strategies and Today’s Bounce Alert is Everlet, Inc. Analyst Reports by Smal...
2014年10月16日 - 12:56AM
InvestorsHub NewsWire
Burton, MI - October 15,2014 - InvestorsHub NewsWire -
Sanomedics International Holdings, Inc. (OTCQB:
SIMH) is a medical technology holding company that focuses on
game changing products, services and ideas; a place where
physicians, entrepreneurs, and medical companies can work together
to drive innovative technologies through concept, development, and
ultimately commercialization. Sanomedics plans to grow existing
business organically and through strategic acquisitions
specifically relating to healthcare technology and services.
View the report at the link to see how the company’s Thermomedics
division’s Caregiver Touchfree thermometer is being deployed to
ports of entry to detect fevers: http://bit.ly/-SIMH-AnalystReport
Hemispherx BioPharma, Inc. (NYSE-MKT:
HEB) is an advanced specialty pharmaceutical company.
Hemispherx's flagship products include Alferon N Injection(R) and
the experimental therapeutics Ampligen(R) and Alferon(R) LDO.
Ampligen(R) is an experimental RNA nucleic acid being developed for
globally important debilitating diseases and disorders of the
immune system, including Chronic Fatigue Syndrome. Hemispherx's
platform technology includes components for potential treatment of
various severely debilitating and life threatening diseases.
Read about the company’s collaborations to battle the Ebola virus,
along with a detailed report on the virus at this link: http://bit.ly/-HEB-AnalystReport
GenuFoods Energy Enzyme Corp. (OTCBB:
GFOO) is a development stage company. They distribute an enzyme
dietary supplement for human and animal consumption. ProCellax and
ProAnilax are brands owned by them and are trade mark registered in
the United States of America, China, Hong Kong, Macau, Taiwan,
Thailand, Malaysia, Singapore and Sri
Lanka.
Get your full analyst Report here: http://bit.ly/-GFOO-AnalystReport
Creative Edge Nutrition, Inc. (OTCBB:
FITX) is a holding company and a Nutritional Supplement Company
focused on developing innovative, high quality supplements. The
company offers a broad spectrum of capsules, tablets, and powders,
as well as science based products in the principal categories of
weight management, nutrition challenges, energy and fitness. The
Company manufactures under strict GMP guidelines at GMP Certified
and/or FDA registered facilities. CEN Biotech, Inc. is a partially
owned subsidiary of FITX for the sole purpose of supplying the
Canadian public with pharmaceutical-grade medical cannabis
For information and updates regarding the company’s cannabis
business follow the link to read a full report: http://bit.ly/-FITX-AnalystReport
About Small Cap Street
Once you read our reports written by our team of financial analysts
you will understand that we make every effort to provide
informative equity research reports for interested parties at no
cost.
Our Financial Analysts spend countless hours researching stocks.
They include stocks traded in the NYSE, NASDAQ, and OTCBB
exchanges. These reports include a straightforward assessment of
the company by a financial analyst who has pledged to remain free
of influence when writing research reports.
FORWARD-LOOKING DISCLAIMER
This report may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, and is subject to the Safe Harbor created by those
sections. This material contains statements about expected future
events and/or financial results that are forward-looking in nature
and subject to risks and uncertainties. Such forward- looking
statements by definition involve risks, uncertainties and other
factors, which may cause the actual results, performance or
achievements of mentioned company to be materially different from
the statements made herein.
A full disclaimer can be found by viewing the full analyst
report.
If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at editor@smallcapstreet.com. For any urgent concerns or inquiries
please contact us at editor@smallcapstreet.com.
Source: Small Cap Street, LLC
Genufood Energy Enzymes (CE) (USOTC:GFOO)
過去 株価チャート
から 11 2024 まで 12 2024
Genufood Energy Enzymes (CE) (USOTC:GFOO)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Genufood Energy Enzymes Corporation (CE) (その他OTC): 0 recent articles
その他のGenufood Energy Enzymes Corp. (PC)ニュース記事